Interpretable Multimodal Fusion Model for Bridged Histology and Genomics Survival Prediction in Pan-Cancer

  • 0Department of General Surgery (Department of Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.

Summary

This summary is machine-generated.

This study introduces an interpretable AI model fusing histopathology, genomics, and transcriptomics for accurate cancer prognosis. The model performs well even with missing patient data, aiding clinical decisions.

Area Of Science

  • Oncology
  • Artificial Intelligence
  • Medical Informatics

Background

  • Accurate cancer prognosis is vital for effective clinical diagnosis and treatment planning.
  • Multimodal artificial intelligence (AI) fusion models enhance tumor heterogeneity analysis for improved prognosis prediction.
  • Clinical utility of AI models is limited by incomplete multimodal patient data.

Purpose Of The Study

  • To develop an interpretable bridged multimodal fusion model combining histopathology, genomics, and transcriptomics.
  • To improve the precision of cancer patient prognosis, especially when molecular data is missing.
  • To create a clinically applicable AI model for cancer prognosis.

Main Methods

  • Developed an interpretable bridged multimodal fusion model.
  • Integrated histopathology, genomics, and transcriptomics data.
  • Validated the model across 12 cancer types with complete and missing data modalities.

Main Results

  • The model achieved optimal predictive performance across 12 cancer types.
  • Demonstrated high accuracy in both complete and missing data scenarios.
  • Showcased the model's utility for patients with incomplete molecular features.

Conclusions

  • The developed AI model offers precise cancer prognosis predictions, even with missing data.
  • Highlights the potential for clinically applicable multimodal fusion models in oncology.
  • Aims to reduce healthcare burden and enhance clinical decision-making for cancer patients.